News

National data from 2022 to 2023 estimated that for every 1,000 patients prescribed semaglutide, there were less than four emergency department (ED) visits, mainly for gastrointestinal symptoms.
National data from 2022 to 2023 estimated that for every 1,000 patients prescribed semaglutide, there were less than four emergency department (ED) visits, mainly for gastrointestinal symptoms.